Dow Down0.02% Nasdaq Up0.07%

Progenics Pharmaceuticals, Inc. (PGNX)

-NMS
7.08 0.30(4.42%) Nov 25, 4:00PM EST
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Net Income 36,975   (11,073) (9,313) (8,551)
Operating Activities, Cash Flows Provided By or Used In
Depreciation142  133  144  165  
Adjustments To Net Income1,421  1,765  1,230  990  
Changes In Accounts Receivables(40,199)(651)2,062  (2,126)
Changes In Liabilities1,802  255  (2,532)555  
Changes In Inventories -   -   -   -  
Changes In Other Operating Activities(51)906  (906)(730)
Total Cash Flow From Operating Activities 90   (8,665) (9,315) (9,697)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(259)(58)(10)(60)
Investments -   -   -   -  
Other Cash flows from Investing Activities52  30  46  21  
Total Cash Flows From Investing Activities (207) (28) 36   (39)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock -  4  37,455  (1)
Net Borrowings -   -   -   -  
Other Cash Flows from Financing Activities -   -   -   -  
Total Cash Flows From Financing Activities -   4   37,455   (1)
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents (117) (8,689) 28,176   (9,737)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.